| 1 |
35400328 | Effects of Sacubitril/Valsartan Versus Telmisartan in Type 2 Diabetic or Pre-Diabetic Patients with Hypertension and Without Heart Failure: The Rationale and Design of A Randomized Clinical Trial. | 2022 Apr 8 |
1 |
| 2 |
34594226 | Telmisartan Potentiates Insulin Secretion via Ion Channels, Independent of the AT1 Receptor and PPARĪ³. | 2021 |
1 |
| 3 |
29679000 | Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats. | 2018 Apr 21 |
1 |
| 4 |
28330649 | Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial. | 2017 May |
2 |
| 5 |
25137874 | Short-term administration of an angiotensin II receptor blocker in patients with long-term hemodialysis patients improves insulin resistance. | 2014 Jun |
2 |
| 6 |
23837919 | The metabolic cost of lowering blood pressure with hydrochlorothiazide. | 2013 Jul 9 |
2 |
| 7 |
23863812 | Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia. | 2013 Oct |
2 |
| 8 |
22747613 | Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide? | 2012 Jul |
4 |
| 9 |
24331589 | Angiotensin receptor 1 blocker valsartan normalizes gene expression profiles of 3T3-L1 adipocytes altered by co-culture with LPS-treated RAW264.7 macrophages. | 2012 Oct-Dec |
2 |
| 10 |
21185798 | Diabetes prevention: can insulin secretagogues do the job? | 2011 Jul |
1 |
| 11 |
21330640 | Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial. | 2011 Apr |
6 |
| 12 |
21844821 | Valsartan-induced improvement in insulin sensitivity is not paralleled by changes in microvascular function in individuals with impaired glucose metabolism. | 2011 Oct |
6 |
| 13 |
20493430 | Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus. | 2010 Jun |
1 |
| 14 |
20498618 | Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives. | 2010 Aug |
2 |
| 15 |
25649195 | Open-label, Randomized Crossover Study Between Telmisartan and Valsartan on Improving Insulin Resistance and Adipocytokines in Nondiabetic Patients with Mild Hypertension. | 2010 |
3 |
| 16 |
18981627 | Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients. | 2008 |
2 |
| 17 |
17635748 | Effect of angiotensin II receptor blockers on insulin resistance in maintenance haemodialysis patients. | 2007 Aug |
1 |
| 18 |
17827829 | Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome. | 2007 |
2 |
| 19 |
18370779 | Valsartan Improves Insulin Sensitivity without Altering Vascular Function in Healthy Overweight Adults without the Metabolic Syndrome. | 2007 Sep |
2 |
| 20 |
16097363 | Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients. | 2005 Mar |
1 |
| 21 |
11921494 | The effects of valsartan on insulin sensitivity in patients with primary hypertension. | 2002 Jan-Feb |
3 |
| 22 |
12063642 | Acute effects of valsartan on insulin sensitivity in obese, non-hypertensive subjects with and without type 2 diabetes. | 2002 May |
2 |